3 AI ETFs With 70%+ Upside to Buy in September, According to Analysts
AI spending keeps rising across chips, cloud, and next‑gen software, and a few AI-focused ETFs still offer big upside. Three funds – Invesco NASDAQ...
10X Genomics Inc. (TXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 10,003,057 | $383,517,223 | -15% | 2.49% |
| 2. | Quantinno Capital Hoon Kim | 5,469,698 | $209,708,221 | +2% | 0.25% |
| 3. | Citadel Investment Group Ken Griffin | 2,779,213 | $106,555,026 | +274% | 0.01% |
| 4. | AQR Capital Management Cliff Asness | 2,026,464 | $74,695,463 | -21% | 0.03% |
| 5. | Point72 Asset Management Steve Cohen | 1,852,776 | $71,035,432 | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.14 | 40,000 | $445,572.00 | 61,691 | 2025-02-21 | Filing | |
| $40.49 | 158 | $6,396.71 | 60,046 | 2022-05-13 | Filing | |
| $40.49 | 158 | $6,396.71 | 97,523 | 2022-05-13 | Filing | |
| $39.00 | 300,000 | $11,700,000.00 | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 300,000 | $11,700,000.00 | 300,000 | 2019-09-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $64.75 | 492 | $31,855.28 | 1,075,349 | 2026-08-26 | Filing | |
| $63.98 | 6,494 | $415,465.34 | 1,075,841 | 2026-08-26 | Filing | |
| $63.02 | 3,500 | $220,580.15 | 1,082,335 | 2026-08-26 | Filing | |
| $63.02 | 18,545 | $1,168,774.52 | 1,085,835 | 2026-08-24 | Filing | |
| $63.02 | 17,166 | $1,081,852.82 | 362,732 | 2026-08-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,629,266 | $675,906,044 | 0.03% | |
| 2. | 10,804,070 | $414,228,044 | 0.01% | |
| 3. | 6,982,492 | $267,708,743 | 0.01% | |
| 4. | 5,082,594 | $194,866,654 | 0% | |
| 5. | 4,194,627 | $160,821,999 | 0.09% |
News See All
Cathie Wood Buys the Dip with $41M in Broadcom, Cerebras, and Rocket Lab Shares; Sells $19M of Roblox
Cathie Wood’s ARK Invest used Wednesday’s market weakness to add $41.2 million worth of Broadcom ($AVGO), Cerebras Systems ($CBRS), and Rocket Lab ...
10x Genomics (TXG) Sees Strong Early Orders for New Atera Platform
On August 6, 10x Genomics (NASDAQ:TXG) reported second-quarter revenue of $151 million, boosted by a $1.6 million settlement payment from Takara.
10x Genomics, Inc. (NASDAQ:TXG) Q1 2026 Earnings Call Transcript
10x Genomics, Inc. (NASDAQ:TXG) Q1 2026 Earnings Call Transcript May 7, 202610x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.27.
10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript
10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript February 12, 202610x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.19.
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks.
7 Most Promising Gene Editing Stocks According to Analysts
In this article, we will be taking a look at the 7 Most Promising Gene Editing Stocks According to Analysts.
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch
10x Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now.
10 Best Digital Health Stocks to Buy Now
Digital health’s 2025 shape is pretty clear: money is flowing again, AI is getting absorbed into real workflows, and policy is quietly forcing the pipes to talk to each other.
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat
We recently published 10 Stocks Beating the Market with Eye-Popping Gains. 10x Genomics Inc. (NASDAQ:TXG) is one of the best-performing stocks on Monday.
Hedge Fund Resource Center